Wordt geladen...
Sorafenib for relapsed FLT3‐ITD‐positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis
Relapse of FLT3‐mutated acute myeloid leukemia (AML) following allogeneic stem cell transplantation is associated with poor survival. The clinical utility of sorafenib monotherapy in this setting is described in a patient presenting as leukemia cutis.
Bewaard in:
| Gepubliceerd in: | Clin Case Rep |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6935638/ https://ncbi.nlm.nih.gov/pubmed/31893105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2487 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|